Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-06

Clinical Trial Update: Kombucha in Overweight and Obese: Live Vs. Pasteurized Effects on Microbiota, Metabolism, and Liver Function [NA]

View source ↗

Summary

A clinical trial is evaluating the effects of live versus pasteurized kombucha on gut microbiota, metabolism, and liver function in individuals with obesity or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kombucha beverage (live vs. pasteurized)

Snippet

Sponsor: Associação Centro de Apoio Tecnológico Agro Alimentar | Conditions: Obesity and Overweight | NA | Status: RECRUITING